Korean J Biol Psychiatry.
2013 May;20(2):29-30.
Ketamine as a Rapid-Acting Antidepressant
- Affiliations
-
- 1Department of Neuropsychiatry, Hanyang University College of Medicine, Guri Hospital, Guri, Korea. daeyoh@kaist.ac.kr
Abstract
- First-line therapy of depression is a pharmacological treatment. Many prescribed antidepressants modulate monoamine neurotransmitters including serotonin, norepinephrine and dopamine. Recently, Ketamine, an N-methyl-D-aspartate receptor antagonist, has received attention and has been investigated for clinical trials and neurobiological studies. Here, I introduce ketamine as a rapid-acting antidepressant.